Paradigm shift in tuberculosis treatment
A large-scale genome analysis of over 10,000 pathogen strains has shown that genome sequencing can improve tuberculosis treatment. Furthermore: the method has the potential to completely replace time-intensive phenotypic resistance testing.
Combination antibody therapy results in long-term viral suppression in HIV infection
Scientists at the University Hospital Cologne and the German Center for Infection Research, have investigated the impact of combining broadly neutralising antibodies in HIV-infected patients.
A helper with foresight
Christoph Lange was recently appointed as Medical Director of the Research Center Borstel. From here, he substantially contributes to clinical tuberculosis research in Europe, also monitoring the development and treatment of multidrug-resistant cases. Learn more about his work.
05 October 2018 - PRESS RELEASE
Ebola, Nipah and new emerging viruses: 'Plug-and-Play' for the rapid production of protective antibodies
Epidemics caused by dangerous pathogens such as Ebola virus can occur without warning. The administration of protective antibodies against a pathogen is one approach to save lives and reduce the number of victims. DZIF scientists at the Paul Ehrlich Institute in Langen and at Universities in Marburg and Munich have shown how these antibodies could be produced quickly and in large quantities in animals in the event of outbreaks. [ more ]
28 September 2018 - PRESS RELEASE
27 September 2018 - PRESS RELEASE
DZIF e. V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL firstname.lastname@example.org